Compare Futu Holdings Ltd (FUTU) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Futu Holdings Ltd vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Futu Holdings Ltd trades at $109.09 (market cap $15.35B), while GE HealthCare Technologies Inc. Common Stock trades at $70.77 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2× Futu Holdings Ltd's market cap, and Futu Holdings Ltd pays the higher dividend (2.37%). Which is the better fit depends on your goals.
| FUTU | GEHC | |
|---|---|---|
Market Cap | $15.35B | $30.93B |
Volume | 1,329,666 | 5,033,451 |
Sector | Financials | Health |
52-Week High | $199.04 | $88.16 |
52-Week Low | $89.76 | $59.48 |
Typical Hold Time | 34 Days | — |
Enterprise Value | $15.69B | $39.39B |
Dividend Yield | 2.37% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Futu Holdings trades at $114.06, up 1.6% today, with a neutral technical signal and bullish moving averages. The company reported strong revenue growth, with 2025 revenue reaching $22.85 billion and net income of $11.34 billion, though Q1 2026 earnings missed expectations. Analyst sentiment is positive with a 58.34% buy rating, and recent news highlights expansion initiatives like the Moomoo platform's partnership with X's Cashtag program.
The outlook for Futu is cautiously optimistic, supported by robust profitability and overseas growth potential, but risks include ongoing class-action lawsuits and earnings volatility. Wall Street sees a 33.7% upside potential, making it attractive for growth-oriented investors despite regulatory and competitive headwinds.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
